Phylogenetic associations with drug-resistant Mycobacterium tuberculosis isolates in a paediatric population

J Arora1, Z Sidiq1, S Sharma2

  • 1Department of Microbiology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.

Insights

Drug resistance is high in pediatric tuberculosis (TB) patients, with Beijing and CAS1-Delhi strains driving active transmission. This highlights the need for targeted interventions against these resistant Mycobacterium tuberculosis strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Pediatric tuberculosis (TB) serves as an indicator of community disease transmission.
  • Understanding drug resistance and phylogenetic patterns in pediatric TB is crucial for public health.

Purpose of the Study:

  • To investigate drug resistance patterns of Mycobacterium tuberculosis complex strains from children.
  • To explore the phylogenetic associations of these strains.

Main Methods:

  • Analyzed 97 Mycobacterium tuberculosis complex strains from 111 pediatric TB patients (2009-2011).
  • Performed drug susceptibility testing (DST) against four first-line drugs.
  • Conducted spoligotyping to determine phylogenetic clusters.

Main Results:

  • 68% of strains were resistant to at least one drug; 56.7% were multidrug-resistant (isoniazid and rifampicin resistance).
  • The majority (90%) belonged to principal genetic group 1.
  • Predominant spoligotyping clusters were SIT1/Beijing (28 strains) and SIT26/CAS1-Delhi (27 strains).

Conclusions:

  • Beijing and CAS1-Delhi lineages are significantly involved in pediatric TB.
  • These clades likely play a major role in the ongoing active transmission of tuberculosis.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
972
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
797
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
80
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K